Table 2. Literature on P. mendocina.

Publication Year	Location	Age/Sex	Infection type	Treatment regimen
1992 [9]	Argentina	63/Male	Endocarditis	IV ceftriaxone + IV gentamicin x6 weeks followed by oral ciprofloxacin x2 weeks
2001 [2]	Denmark	28/Female	Endocarditis	IV gentamicin + IV ampicillin followed by ciprofloxacin
2005 [10]	Taiwan	65/Male	Spondylodiscitis	IV cefepime x6 weeks, followed by oral ciprofloxacin x4 weeks
2007 [11]	Turkey	36/Male	Endocarditis	IV ceftazidime + IV amikacin x6 weeks
2011 [12]	France	79/Female	Endocarditis	IV piperacillin + IV gentamicin x6 weeks
2011 [13]	Israel	31/Male	Bacteremia	IV gentamicin + oral ofloxacin x2 weeks
2012 [6]	Singapore	86/Female	Osteomyelitis	N/A
2013 [7]	Singapore	34/Male	Septic arthritis	Oral trimethoprim sulfamethoxazole x16 days
2016 [3]	United States	57/Male	Endocarditis	IV piperacillin/tazobactam x6 weeks
2017 [14]	Portugal	22/Male	Peritonitis	Intraperitoneal cefazolin + intraperitoneal ceftazidime followed by oral ciprofloxacin x3 weeks
2018 [15]	Argentina	56/Male	Skin/soft tissue	Ampicillin sulbactam/colistin
2018 [15]	Argentina	36/Male	Skin/soft tissue	Colistin
2018 [16]	Taiwan	55/Male	Meningitis	IV ceftriaxone
2018 [16]	Taiwan	66/Female	Meningitis	IV ceftazidime
2018 [16]	Taiwan	79/Male	Meningitis	IV meropenem
2018 [16]	Taiwan	78/Female	Meningitis	IV cefepime
2019 [4]	United States	63/Male	Bacteremia	Ceftazidime x10 days
2020 [5]	United States	72/Male	Bacteremia	IV piperacillin/tazobactam followed by oral ciprofloxacin x2 weeks
This report	United States	81/Male	Bacteremia	IV cefepime followed by oral ciprofloxacin x2 weeks